Slate Path Capital LP 13D and 13G filings for Cyclerion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-06 4:05 pm Sale |
2024-11-30 | 13G | Cyclerion Therapeutics, Inc. CYCN |
Slate Path Capital LP | 0 0.000% |
-357,880 (Position Closed) |
Filing |
| 2024-01-22 3:44 pm Purchase |
2023-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN |
Slate Path Capital LP | 357,880 14.600% |
357,880 (New Position) |
Filing |